370 related articles for article (PubMed ID: 25498990)
1. Molecular genetics of chronic neutrophilic leukemia, chronic myelomonocytic leukemia and atypical chronic myeloid leukemia.
Li B; Gale RP; Xiao Z
J Hematol Oncol; 2014 Dec; 7():93. PubMed ID: 25498990
[TBL] [Abstract][Full Text] [Related]
2. Specific molecular mutation patterns delineate chronic neutrophilic leukemia, atypical chronic myeloid leukemia, and chronic myelomonocytic leukemia.
Meggendorfer M; Haferlach T; Alpermann T; Jeromin S; Haferlach C; Kern W; Schnittger S
Haematologica; 2014 Dec; 99(12):e244-6. PubMed ID: 25239264
[No Abstract] [Full Text] [Related]
3. CSF3R-mutant chronic myelomonocytic leukemia is a distinct clinically subset with abysmal prognosis: a case report and systematic review of the literature.
Guastafierro V; Ubezio M; Manes N; Milanesi C; Della Porta M; Bonometti A
Leuk Lymphoma; 2023 Sep; 64(9):1566-1573. PubMed ID: 37395413
[TBL] [Abstract][Full Text] [Related]
4. [Molecular characterization of atypical chronic myeloid leukemia and chronic neutrophilic leukemia].
Senín A; Arenillas L; Martínez-Avilés L; Fernández-Rodríguez C; Bellosillo B; Florensa L; Besses C; Álvarez-Larrán A
Med Clin (Barc); 2015 Jun; 144(11):487-90. PubMed ID: 24854193
[TBL] [Abstract][Full Text] [Related]
5. Molecular pathogenesis of atypical CML, CMML and MDS/MPN-unclassifiable.
Zoi K; Cross NC
Int J Hematol; 2015 Mar; 101(3):229-42. PubMed ID: 25212680
[TBL] [Abstract][Full Text] [Related]
6. t(5;12)(q31;p12). A clinical entity with features of both myeloid leukemia and chronic myelomonocytic leukemia.
Wessels JW; Fibbe WE; van der Keur D; Landegent JE; van der Plas DC; den Ottolander GJ; Roozendaal KJ; Beverstock GC
Cancer Genet Cytogenet; 1993 Jan; 65(1):7-11. PubMed ID: 8431918
[TBL] [Abstract][Full Text] [Related]
7. Diagnosis and management of neutrophilic myeloid neoplasms.
Schwede M; Gotlib J; Shomali W
Clin Adv Hematol Oncol; 2021 Jul; 19(7):450-459. PubMed ID: 34236344
[TBL] [Abstract][Full Text] [Related]
8. The new genetics of chronic neutrophilic leukemia and atypical CML: implications for diagnosis and treatment.
Gotlib J; Maxson JE; George TI; Tyner JW
Blood; 2013 Sep; 122(10):1707-11. PubMed ID: 23896413
[TBL] [Abstract][Full Text] [Related]
9. Atypical chronic myeloid leukemia as defined in the WHO classification is a JAK2 V617F negative neoplasm.
Fend F; Horn T; Koch I; Vela T; Orazi A
Leuk Res; 2008 Dec; 32(12):1931-5. PubMed ID: 18555525
[TBL] [Abstract][Full Text] [Related]
10. Making sense of the myelodysplastic/myeloproliferative neoplasms overlap syndromes.
Tiu RV; Sekeres MA
Curr Opin Hematol; 2014 Mar; 21(2):131-40. PubMed ID: 24378705
[TBL] [Abstract][Full Text] [Related]
11. Chronic myelomonocytic leukemia and atypical chronic myeloid leukemia: novel pathogenetic lesions.
Muramatsu H; Makishima H; Maciejewski JP
Semin Oncol; 2012 Feb; 39(1):67-73. PubMed ID: 22289493
[TBL] [Abstract][Full Text] [Related]
12. Recent Progress in Chronic Neutrophilic Leukemia and Atypical Chronic Myeloid Leukemia.
Dao KT; Tyner JW; Gotlib J
Curr Hematol Malig Rep; 2017 Oct; 12(5):432-441. PubMed ID: 28983816
[TBL] [Abstract][Full Text] [Related]
13. Identification of a rare e6a2 BCR-ABL fusion gene during the disease progression of chronic myelomonocytic leukemia: a case report.
Hayette S; Tigaud I; Thomas X; French M; Perrin MC; Nicolini F; Michallet M; Magaud JP
Leukemia; 2004 Oct; 18(10):1735-6. PubMed ID: 15356652
[No Abstract] [Full Text] [Related]
14. Oncogenic CSF3R mutations in chronic neutrophilic leukemia and atypical CML.
Maxson JE; Gotlib J; Pollyea DA; Fleischman AG; Agarwal A; Eide CA; Bottomly D; Wilmot B; McWeeney SK; Tognon CE; Pond JB; Collins RH; Goueli B; Oh ST; Deininger MW; Chang BH; Loriaux MM; Druker BJ; Tyner JW
N Engl J Med; 2013 May; 368(19):1781-90. PubMed ID: 23656643
[TBL] [Abstract][Full Text] [Related]
15. Chronic neutrophilic leukemia (CNL) with karyotypic abnormalities associated with plasma cell dyscrasia: a case report.
Masini L; Salvarani C; Macchioni P; Baldi G; Rossi F; Croci G; Prandi S; Davoli C; Portioli I; Gobbi F
Haematologica; 1992; 77(3):277-9. PubMed ID: 1427435
[TBL] [Abstract][Full Text] [Related]
16. Diagnosing myelodysplastic/myeloproliferative neoplasms: laboratory testing strategies to exclude other disorders.
Hall J; Foucar K
Int J Lab Hematol; 2010 Dec; 32(6 Pt 2):559-71. PubMed ID: 20670271
[TBL] [Abstract][Full Text] [Related]
17. A diagnostic dilemma: chronic myelomonocytic leukemia versus atypical chronic myeloid leukemia. A case report and review of the literature.
Misialek MJ; Pechet L
Acta Haematol; 1997; 98(4):221-7. PubMed ID: 9401502
[TBL] [Abstract][Full Text] [Related]
18. The myelodysplastic/myeloproliferative neoplasms: myeloproliferative diseases with dysplastic features.
Orazi A; Germing U
Leukemia; 2008 Jul; 22(7):1308-19. PubMed ID: 18480833
[TBL] [Abstract][Full Text] [Related]
19. Molecular genetics of MDS/MPN overlap syndromes.
Hunter AM; Padron E
Best Pract Res Clin Haematol; 2020 Sep; 33(3):101195. PubMed ID: 33038984
[TBL] [Abstract][Full Text] [Related]
20. CSF3R is mutated in chronic neutrophilic leukemia and atypical CML.
Cancer Discov; 2013 Jul; 3(7):OF23. PubMed ID: 23847367
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
